| dc.contributor.author | Douglas S Walsh, Fredrick Eyase, David Onyango, Alfred Odindo, Walter Otieno, John N Waitumbi, Wallace D Bulimo, David C Schnabel, Wayne M Meyers, Françoise Portaels | |
| dc.date.accessioned | 2020-11-18T06:45:38Z | |
| dc.date.available | 2020-11-18T06:45:38Z | |
| dc.date.issued | 2009 | |
| dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/2813 | |
| dc.description.abstract | Mycobacterium ulcerans infection is an emerging disease that causes indolent, necrotizing skin lesions known
as Buruli ulcer (BU) and occasional contiguous or metastatic bone lesions. Buruli ulcer is named after Buruli County in
Uganda (east Africa), where an epidemic occurred in the 1960s. Today, BU is most common in central and west Africa. We
describe clinical and molecular evidence for a case of BU in Kenya. | en_US |
| dc.publisher | The American Society of Tropical Medicine and Hygiene | en_US |
| dc.title | Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya | en_US |
| dc.type | Article | en_US |
